JP2019523226A5 - - Google Patents

Download PDF

Info

Publication number
JP2019523226A5
JP2019523226A5 JP2018564844A JP2018564844A JP2019523226A5 JP 2019523226 A5 JP2019523226 A5 JP 2019523226A5 JP 2018564844 A JP2018564844 A JP 2018564844A JP 2018564844 A JP2018564844 A JP 2018564844A JP 2019523226 A5 JP2019523226 A5 JP 2019523226A5
Authority
JP
Japan
Prior art keywords
sbt
oil
pufa
pharmaceutical composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018564844A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019523226A (ja
JP7518604B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/036330 external-priority patent/WO2017214260A1/en
Publication of JP2019523226A publication Critical patent/JP2019523226A/ja
Publication of JP2019523226A5 publication Critical patent/JP2019523226A5/ja
Application granted granted Critical
Publication of JP7518604B2 publication Critical patent/JP7518604B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018564844A 2016-06-07 2017-06-07 タキソイド薬物のナノエマルション組成物、並びに標的癌細胞及び癌幹細胞に対するその使用方法 Active JP7518604B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662346755P 2016-06-07 2016-06-07
US62/346,755 2016-06-07
PCT/US2017/036330 WO2017214260A1 (en) 2016-06-07 2017-06-07 Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells

Publications (3)

Publication Number Publication Date
JP2019523226A JP2019523226A (ja) 2019-08-22
JP2019523226A5 true JP2019523226A5 (https=) 2020-07-27
JP7518604B2 JP7518604B2 (ja) 2024-07-18

Family

ID=60578981

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018564844A Active JP7518604B2 (ja) 2016-06-07 2017-06-07 タキソイド薬物のナノエマルション組成物、並びに標的癌細胞及び癌幹細胞に対するその使用方法

Country Status (9)

Country Link
US (3) US10206875B2 (https=)
EP (1) EP3463299A4 (https=)
JP (1) JP7518604B2 (https=)
CN (2) CN109562065A (https=)
AU (1) AU2017277497B2 (https=)
CA (1) CA3026412A1 (https=)
IL (1) IL263504A (https=)
MX (1) MX2018015112A (https=)
WO (1) WO2017214260A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017214260A1 (en) * 2016-06-07 2017-12-14 Targagenix, Inc. Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells
CN112996501A (zh) * 2017-12-20 2021-06-18 塔佳吉尼克斯公司 癌症中紫杉类纳米乳剂与免疫疗法的联合
JP7610208B2 (ja) * 2019-03-22 2025-01-08 インテグレイテッド ナノセラピューティクス インコーポレイテッド 足場部分から調製した脂質結合体
EP4048310A4 (en) * 2019-10-25 2024-03-13 Amgen Inc. COMPOSITIONS AND METHODS FOR MINIMIZING PROTEIN LOSS AT LOW PROTEIN CONCENTRATIONS
EP4054550A4 (en) * 2019-11-05 2024-01-17 Luminus Biosciences Inc. NANOPARTICLES WITH PRODRUGS STABILIZED BY ALBUMIN FOR THE TREATMENT OF CANCER AND OTHER DISEASES
CN111004195B (zh) * 2019-12-03 2022-01-28 沈阳药科大学 卡巴他赛弱碱性衍生物及其制剂
CN114317398B (zh) * 2020-09-27 2024-03-01 中国科学院分子细胞科学卓越创新中心 Gli1和EpCAM基因共同标记的肝祖细胞群及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426367B1 (en) * 1999-09-09 2002-07-30 Efa Sciences Llc Methods for selectively occluding blood supplies to neoplasias
CN1901901B (zh) * 2003-10-30 2012-07-04 纽约州州立大学研究基金会 紫杉醇-脂肪酸结合物及其药物组合物
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20070148194A1 (en) * 2005-11-29 2007-06-28 Amiji Mansoor M Novel nanoemulsion formulations
JP5635504B2 (ja) * 2008-07-23 2014-12-03 ブハラット セルムズ アンド ヴァクシンズ リミテッド 安定した注射可能な水中油型ドセタキセルナノエマルション
US20100021471A1 (en) * 2008-07-25 2010-01-28 Brookhaven Science Associates, Llc Carbon nanotube-based drug delivery systems and methods of making same
US20140105829A1 (en) * 2012-10-15 2014-04-17 Nemucore Medical Innovations, Inc. Therapeutic nanoemulsion formulation for the targeted delivery of docetaxel and methods of making and using the same
SG11201609352TA (en) * 2014-06-19 2017-01-27 Solural Pharma ApS Solid oral dosage form of lipophilic compounds
WO2015198350A1 (en) * 2014-06-25 2015-12-30 Synergia Bio Sciences Private Limited A pharmaceutical oil-in-water nano-emulsion
WO2017214260A1 (en) * 2016-06-07 2017-12-14 Targagenix, Inc. Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells
CN112996501A (zh) * 2017-12-20 2021-06-18 塔佳吉尼克斯公司 癌症中紫杉类纳米乳剂与免疫疗法的联合

Similar Documents

Publication Publication Date Title
JP2019523226A5 (https=)
Panzarini et al. Novel therapeutic delivery of nanocurcumin in central nervous system related disorders
Delshadi et al. Micro and nano-encapsulation of vegetable and essential oils to develop functional food products with improved nutritional profiles
Kulawik-Pióro et al. Polymeric gels and their application in the treatment of psoriasis vulgaris: A review
Liu et al. Salidroside promotes peripheral nerve regeneration based on tissue engineering strategy using Schwann cells and PLGA: in vitro and in vivo
Sonu Ambwani et al. Current knowledge on nanodelivery systems and their beneficial applications in enhancing the efficacy of herbal drugs.
AU2015211711B2 (en) Orally administered agent for ruminants and ruminant feed containing same
Eskandani et al. Formulation, characterization, and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles
Blanco-Llamero et al. Nutraceuticals and food-grade lipid nanoparticles: from natural sources to a circular bioeconomy approach
US20250009658A1 (en) Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells
Gadad et al. Moxifloxacin loaded polymeric nanoparticles for sustained ocular drug delivery
Rambaran A patent review of polyphenol nano-formulations and their commercialization
Andronescu et al. Nanostructures for oral medicine
Liu et al. Advances in transdermal drug delivery systems and clinical applications in inflammatory skin diseases
Ratan et al. Nano-based formulations of curcumin: elucidating the potential benefits and future prospects in skin cancer
Jahangir et al. Transdermal nutraceuticals delivery system for CNS disease
Shen et al. Advancements in Antioxidant-Based therapeutics for spinal cord injury: A critical review of strategies and combination approaches
Bhushani et al. Nanodelivery of nutrients for improved bioavailability
Fatima et al. Nutraceutical formulations and natural compounds for the management of chronic diseases
JP2021517906A5 (https=)
Jiang et al. Food-grade nanostructured delivery systems for oral administration of astaxanthin: Bioprocessing strategies and therapeutic applications
CN112040935A (zh) 诱导哺乳动物饱腹感的方法
Kim et al. Nanoparticle encapsulation of the hexane fraction of Cyperus Rotundus extract for enhanced antioxidant and anti-Inflammatory activities in vitro
de Oliveira Filho et al. Bioavailability and delivery mechanisms of nutraceuticals in nanoparticles derived from biopolymers
Saadatpour et al. Potential of nanoparticles and nanopolymers in treatment of age-associated diseases